100 UG RP LILRA5
|
Invitrogen Human LILRA5 (CD85f, LIR-9) His-tag Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: A6NI73,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formul
|
3136-RP88119
|
EA
|
|
100 UG RP LILRA5
|
Invitrogen Human LILRA5 (CD85f, LIR-9) Fc Chimera Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: A6NI73,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, For
|
3136-RP88117
|
EA
|
|
1 MG RP LILRA5
|
Invitrogen Human LILRA5 (CD85f, LIR-9) His-tag Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: A6NI73,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formulat
|
3136-RP88120
|
EA
|
|
1 MG RP LILRA5
|
Invitrogen Human LILRA5 (CD85f, LIR-9) Fc Chimera Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: A6NI73,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formu
|
3136-RP88118
|
EA
|
|
100 UG RP BTN3A2
|
Invitrogen Human BTN3A2 His-tag Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: P78410,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formulation: PBS with
|
3136-RP87960
|
EA
|
|